Metraipolis › archive › dc_bf106a81685e

Targeting PKM2 in cancer therapeutics: mechanistic advances and translational opportunities — Europe PMC PMID:41169372

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41169372
DOI
10.3389/fimmu.2025.1649488
License (as archived)
solo-consultazione
Archived
2026-11-09T07:48:44.938Z
SHA-256 of the archived text
b4698d389f5925a42bba62193bce128341c1274603aa02a77de4f658969ae054
Stable URL of this page
https://metraipolis.com/documento/dc_bf106a81685e

How to cite

Targeting PKM2 in cancer therapeutics: mechanistic advances and translational opportunities — Europe PMC PMID:41169372 — Europe PMC (en), https://europepmc.org/article/MED/41169372 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf106a81685e (Metraipolis archive dc_bf106a81685e, sha256 b4698d389f5925a42bba62193bce128341c1274603aa02a77de4f658969ae054)
BibTeX
@misc{dcbf106a81685e,
  title = {Targeting PKM2 in cancer therapeutics: mechanistic advances and translational opportunities — Europe PMC PMID:41169372},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41169372},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf106a81685e; sha256 b4698d389f5925a42bba62193bce128341c1274603aa02a77de4f658969ae054},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41169372. Agents can read the archived copy with the MCP tool read_document.